Yannan Yang

7.5k total citations · 2 hit papers
121 papers, 6.3k citations indexed

About

Yannan Yang is a scholar working on Materials Chemistry, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Yannan Yang has authored 121 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Materials Chemistry, 47 papers in Molecular Biology and 47 papers in Biomedical Engineering. Recurrent topics in Yannan Yang's work include Nanoplatforms for cancer theranostics (34 papers), RNA Interference and Gene Delivery (24 papers) and Nanoparticle-Based Drug Delivery (20 papers). Yannan Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (34 papers), RNA Interference and Gene Delivery (24 papers) and Nanoparticle-Based Drug Delivery (20 papers). Yannan Yang collaborates with scholars based in Australia, China and Singapore. Yannan Yang's co-authors include Chengzhong Yu, Hao Song, Jun Zhang, Meihua Yu, Yue Wang, Zhengying Gu, C. F. Xu, Jie Tang, Yiru Shi and Hongwei Zhang and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Yannan Yang

118 papers receiving 6.2k citations

Hit Papers

Antibiotic‐Free Antibacterial Strategies Enabled by Nanom... 2016 2026 2019 2022 2019 2016 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yannan Yang Australia 41 2.6k 2.5k 1.7k 1.3k 706 121 6.3k
Huixia Wu China 42 2.3k 0.9× 2.4k 1.0× 1.4k 0.9× 1.3k 1.0× 587 0.8× 106 6.0k
Hao Song China 46 2.6k 1.0× 2.5k 1.0× 1.3k 0.8× 1.1k 0.8× 460 0.7× 161 6.7k
Lei Ren China 48 3.8k 1.5× 2.2k 0.9× 2.1k 1.3× 1.7k 1.3× 715 1.0× 221 7.9k
Enguo Ju China 48 3.8k 1.4× 4.2k 1.7× 2.3k 1.4× 1.0k 0.8× 421 0.6× 99 7.2k
Meihua Yu China 43 1.5k 0.6× 2.4k 1.0× 1.5k 0.9× 1.2k 0.9× 383 0.5× 150 5.4k
Nana Zhao China 45 3.0k 1.1× 3.1k 1.2× 1.8k 1.1× 1.6k 1.3× 279 0.4× 171 7.4k
Jie Li China 47 3.6k 1.4× 2.2k 0.9× 1.8k 1.1× 1.1k 0.9× 798 1.1× 171 6.7k
Yan Yan China 43 2.5k 0.9× 1.7k 0.7× 2.1k 1.3× 3.0k 2.3× 399 0.6× 131 7.6k
Zhe Yang China 44 2.3k 0.9× 1.1k 0.4× 2.6k 1.5× 1.2k 1.0× 495 0.7× 195 6.6k

Countries citing papers authored by Yannan Yang

Since Specialization
Citations

This map shows the geographic impact of Yannan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yannan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yannan Yang more than expected).

Fields of papers citing papers by Yannan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yannan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yannan Yang. The network helps show where Yannan Yang may publish in the future.

Co-authorship network of co-authors of Yannan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yannan Yang. A scholar is included among the top collaborators of Yannan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yannan Yang. Yannan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yannan, Yu Fu, & Chongming Wu. (2025). Gut microbe-derived pentadecanoic acid could represent a novel health-promoter via multiple pathways. Food & Function. 16(12). 4636–4653. 1 indexed citations
3.
Yang, Huazhe, Lin Ye, Xinyi Ye, et al.. (2024). Bimetallic clusterzymes-loaded dendritic mesoporous silica particle regulate arthritis microenvironment via ROS scavenging and YAP1 stabilization. Bioactive Materials. 42. 613–627. 7 indexed citations
6.
Yang, Yannan, Shiwei Chen, Min Zhang, et al.. (2024). Mesoporous nanoperforators as membranolytic agents via nano- and molecular-scale multi-patterning. Nature Communications. 15(1). 1891–1891. 2 indexed citations
7.
Li, Song, Yannan Yang, Dandan Liu, et al.. (2024). Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38. Frontiers in Immunology. 15. 1398508–1398508. 3 indexed citations
8.
Zhang, Mengmeng, Qiao Wang, Zhenxia Chen, et al.. (2023). Gelothermal Synthesis of Monodisperse MIL‐88A Nanoparticles with Tunable Sizes and Metal Centers for Potential Bioapplications. Small. 19(34). e2301894–e2301894. 21 indexed citations
9.
Wang, Juhong, Fei Shao, Yannan Yang, et al.. (2022). A non‐metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11‐mediated CD133 stability. Cancer Communications. 42(10). 1008–1027. 45 indexed citations
10.
Yu, Zhiguo, et al.. (2022). Non‐PCR Ultrasensitive Detection of Viral RNA by a Nanoprobe‐Coupling Strategy: SARS‐CoV‐2 as an Example. Advanced Healthcare Materials. 11(17). e2200031–e2200031. 4 indexed citations
11.
Wang, Juhong, Renda Li, Hong Cheng, et al.. (2022). The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer. Frontiers in Oncology. 12. 899987–899987. 17 indexed citations
12.
Sun, Sijin, Kailun Fei, Guochao Zhang, et al.. (2021). Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas. Frontiers in Genetics. 11. 617174–617174. 17 indexed citations
13.
Sun, Sijin, Yannan Yang, Juhong Wang, et al.. (2021). Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication. Frontiers in Cell and Developmental Biology. 9. 743724–743724. 4 indexed citations
14.
Dai, Zan, Jie Tang, Zhengying Gu, et al.. (2020). Eliciting Immunogenic Cell Death via a Unitized Nanoinducer. Nano Letters. 20(9). 6246–6254. 107 indexed citations
15.
Zhang, Min, Yannan Yang, & Chengzhong Yu. (2018). Nano‐resoles‐Enabled Elegant Nanostructured Materials. Chemistry - A European Journal. 24(55). 14598–14607. 7 indexed citations
16.
Kalantari, Mohammad, Meihua Yu, Manasi Jambhrunkar, et al.. (2018). Designed synthesis of organosilica nanoparticles for enzymatic biodiesel production. Materials Chemistry Frontiers. 2(7). 1334–1342. 28 indexed citations
17.
Lu, Yao, Yannan Yang, Zhengying Gu, et al.. (2018). Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy. Biomaterials. 175. 82–92. 153 indexed citations
18.
Pan, Dahai, Wei Chen, Xiaodan Huang, et al.. (2018). Solvothermal-assisted evaporation-induced self-assembly of ordered mesoporous alumina with improved performance. Journal of Colloid and Interface Science. 529. 432–443. 17 indexed citations
19.
Hartono, Sandy Budi, et al.. (2016). Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Nanotechnology. 27(50). 505605–505605. 51 indexed citations
20.
Yang, Yannan & Chengzhong Yu. (2015). Advances in silica based nanoparticles for targeted cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 12(2). 317–332. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026